Optimize HF treatment in patients with HFrEF, including BBs, ACE inhibitors/ARB/ARNI, MRAs, and SGLT-2 inhibitors, according to the latest ESC Guidelines on HF management120,250–252,254. Here, SLC5A2 is linked to hydrops fetalis.